GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 129 filers reported holding GW PHARMACEUTICALS PLC in Q2 2016. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,075,000 | -59.5% | 50,000 | -60.0% | 1.08% | -58.6% |
| Q2 2017 | $12,531,000 | -5.6% | 125,000 | +25.0% | 2.60% | +21.0% |
| Q3 2016 | $13,273,000 | +11.5% | 100,000 | -23.1% | 2.15% | -37.4% |
| Q2 2016 | $11,904,000 | +334.3% | 130,000 | +333.3% | 3.44% | +178.6% |
| Q3 2015 | $2,741,000 | -70.2% | 30,000 | -60.0% | 1.23% | -58.7% |
| Q2 2015 | $9,213,000 | +12.3% | 75,000 | -16.7% | 2.98% | +102.4% |
| Q1 2015 | $8,202,000 | +189.8% | 90,000 | +157.1% | 1.48% | -4.0% |
| Q3 2014 | $2,830,000 | +31.9% | 35,000 | +75.0% | 1.54% | +1.5% |
| Q2 2014 | $2,146,000 | +44.6% | 20,000 | -20.0% | 1.51% | +71.9% |
| Q1 2014 | $1,484,000 | – | 25,000 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|